Document Detail


Utility of immunohistochemical detection of high molecular weight cytokeratin for differential diagnosis of proliferative conditions of the prostate.
MedLine Citation:
PMID:  9624554     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Differential diagnosis of adenocarcinoma from other proliferative conditions in the prostate is often problematic. Immunohistochemistry using an antibody (34 beta E12) to high molecular weight cytokeratin, specifically present in basal cells of the prostate, could clearly demonstrate the presence or absence of these cells in the proliferating glands and thus provide an important clue in cancer diagnosis. METHODS: To examine the utility of immunostaining using 34 beta E12, we examined 88 equivocal lesions. Twenty lesions with apparently benign and malignant features were added as controls. We compared the morphologic features of these lesions with their immunoreactivities toward 34 beta E12 on a personal computer display following storage on the MICROPHOT-FXA system. RESULTS: Proliferating glands in all 20 benign lesions had 34 beta E12-reactive basal cells, but none of the malignant lesions did. The equivocal lesions were categorized on morphologic grounds into 2 groups: possibly benign and possibly malignant. Forty-five (51.1%) of the 88 equivocal lesions, were positive for 34 beta E12. These included 35 of the 45 (77.8%) possibly benign lesions and 10 of the 43 (23.3%) possibly malignant lesions. Among the equivocal lesions, 10 considered possibly benign on morphologic grounds showed negative reactivities, and 10 considered possibly malignant showed positive reactivities. Even through comparison on the computer display, no difference in morphology could be discovered between the negative and positive lesions in either group. CONCLUSION: Immunohistochemical procedures using 34 beta E12 are indispensable in the diagnosis of equivocal prostate lesions.
Authors:
M Shin; M Q Fujita; Y Yasunaga; T Miki; A Okuyama; K Aozasa
Related Documents :
20025474 - Diagnostic issues in second opinion consultations in prostate pathology.
21736634 - Bilateral epididymal sperm granulomas following urethrostomy in a german shepherd dog.
3715544 - Rounded atelectasis: a new criterion for benignancy.
23139574 - Pleomorphic adenoma of the soft palate.
18514604 - Squamous cell carcinoma in a linear epidermal nevus.
1174884 - Needling renal cysts and tumours: cytology and radiology.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of urology : official journal of the Japanese Urological Association     Volume:  5     ISSN:  0919-8172     ISO Abbreviation:  Int. J. Urol.     Publication Date:  1998 May 
Date Detail:
Created Date:  1998-08-17     Completed Date:  1998-08-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9440237     Medline TA:  Int J Urol     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  237-42     Citation Subset:  IM    
Affiliation:
Department of Pathology, Osaka University Medical School, Suita, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / chemistry,  diagnosis*,  pathology
Aged
Aged, 80 and over
Antibodies, Monoclonal / diagnostic use*
Diagnosis, Differential
Evaluation Studies as Topic
Humans
Immunohistochemistry / methods*,  standards*
Keratins / analysis*,  chemistry
Male
Middle Aged
Molecular Weight
Prostatic Neoplasms / chemistry,  diagnosis*,  pathology
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 68238-35-7/Keratins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antitumor killer lymphocytes in the peripheral blood of a patient with transitional cell carcinoma o...
Next Document:  Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate.